Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of CAD 235.05 billion. The enterprise value is 305.49 billion.
| Market Cap | 235.05B |
| Enterprise Value | 305.49B |
Important Dates
The last earnings date was Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Nov 6, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.46% |
| Shares Change (QoQ) | +0.91% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 68.48% |
| Float | 5.69B |
Valuation Ratios
The trailing PE ratio is 51.13 and the forward PE ratio is 9.93.
| PE Ratio | 51.13 |
| Forward PE | 9.93 |
| PS Ratio | 2.64 |
| PB Ratio | 1.89 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.24 |
| P/OCF Ratio | 11.84 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.35, with an EV/FCF ratio of 18.47.
| EV / Earnings | 53.96 |
| EV / Sales | 3.39 |
| EV / EBITDA | 8.35 |
| EV / EBIT | 11.67 |
| EV / FCF | 18.47 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.71.
| Current Ratio | 1.42 |
| Quick Ratio | 1.00 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 2.45 |
| Debt / FCF | 5.38 |
| Interest Coverage | 6.83 |
Financial Efficiency
Return on equity (ROE) is 4.47% and return on invested capital (ROIC) is 12.83%.
| Return on Equity (ROE) | 4.47% |
| Return on Assets (ROA) | 5.59% |
| Return on Invested Capital (ROIC) | 12.83% |
| Return on Capital Employed (ROCE) | 10.70% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.20M |
| Profits Per Employee | 76,025 |
| Employee Count | 75,000 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.49 |
Taxes
In the past 12 months, Pfizer has paid 262.97 million in taxes.
| Income Tax | 262.97M |
| Effective Tax Rate | 4.37% |
Stock Price Statistics
The stock price has increased by +12.83% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +12.83% |
| 50-Day Moving Average | 12.80 |
| 200-Day Moving Average | 12.08 |
| Relative Strength Index (RSI) | 45.32 |
| Average Volume (20 Days) | 90,107 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.00 |
Income Statement
In the last 12 months, Pfizer had revenue of CAD 89.95 billion and earned 5.70 billion in profits. Earnings per share was 0.25.
| Revenue | 89.95B |
| Gross Profit | 67.37B |
| Operating Income | 26.15B |
| Pretax Income | 6.02B |
| Net Income | 5.70B |
| EBITDA | 35.26B |
| EBIT | 26.15B |
| Earnings Per Share (EPS) | 0.25 |
Balance Sheet
The company has 20.19 billion in cash and 89.65 billion in debt, with a net cash position of -69.46 billion.
| Cash & Cash Equivalents | 20.19B |
| Total Debt | 89.65B |
| Net Cash | -69.46B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 126.25B |
| Book Value Per Share | 5.52 |
| Working Capital | 18.78B |
Cash Flow
In the last 12 months, operating cash flow was 20.04 billion and capital expenditures -3.37 billion, giving a free cash flow of 16.66 billion.
| Operating Cash Flow | 20.04B |
| Capital Expenditures | -3.37B |
| Depreciation & Amortization | 9.22B |
| Net Borrowing | 2.50B |
| Free Cash Flow | 16.66B |
| FCF Per Share | n/a |
Margins
Gross margin is 74.90%, with operating and profit margins of 29.07% and 6.34%.
| Gross Margin | 74.90% |
| Operating Margin | 29.07% |
| Pretax Margin | 6.70% |
| Profit Margin | 6.34% |
| EBITDA Margin | 39.19% |
| EBIT Margin | 29.07% |
| FCF Margin | 18.31% |
Dividends & Yields
This stock pays an annual dividend of 0.77, which amounts to a dividend yield of 6.00%.
| Dividend Per Share | 0.77 |
| Dividend Yield | 6.00% |
| Dividend Growth (YoY) | -1.48% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 242.80% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.46% |
| Shareholder Yield | 5.48% |
| Earnings Yield | 1.96% |
| FCF Yield | 7.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pfizer has an Altman Z-Score of 2.25 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.25 |
| Piotroski F-Score | 7 |